US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
FR2413974A1
(fr)
|
1978-01-06 |
1979-08-03 |
David Bernard |
Sechoir pour feuilles imprimees par serigraphie
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
US4681581A
(en)
|
1983-12-05 |
1987-07-21 |
Coates Fredrica V |
Adjustable size diaper and folding method therefor
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
US5101827A
(en)
|
1985-07-05 |
1992-04-07 |
Immunomedics, Inc. |
Lymphographic and organ imaging method and kit
|
US4735210A
(en)
|
1985-07-05 |
1988-04-05 |
Immunomedics, Inc. |
Lymphographic and organ imaging method and kit
|
US5776093A
(en)
|
1985-07-05 |
1998-07-07 |
Immunomedics, Inc. |
Method for imaging and treating organs and tissues
|
US4738681A
(en)
*
|
1985-07-10 |
1988-04-19 |
Harrington Arthritis Research Center |
Femoral-joint prosthetic device
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
EP0279862B1
(en)
|
1986-08-28 |
1993-11-03 |
Teijin Limited |
Cytocidal antibody complex and process for its preparation
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5648471A
(en)
|
1987-12-03 |
1997-07-15 |
Centocor, Inc. |
One vial method for labeling antibodies with Technetium-99m
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
CA2062795A1
(en)
|
1989-06-29 |
1990-12-30 |
Michael W. Fanger |
Bispecific reagents for aids therapy
|
JP3070763B2
(ja)
|
1989-08-09 |
2000-07-31 |
ロメッド インコーポレイティド |
テクネチウムまたはレニウムでの抗体または他のタンパク質の直接放射能標識
|
US5605690A
(en)
*
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
US5370870A
(en)
*
|
1989-10-06 |
1994-12-06 |
Genentech, Inc. |
Method for protection against reactive oxygen species
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
ATE139258T1
(de)
|
1990-01-12 |
1996-06-15 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
US6075181A
(en)
*
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5151510A
(en)
|
1990-04-20 |
1992-09-29 |
Applied Biosystems, Inc. |
Method of synethesizing sulfurized oligonucleotide analogs
|
US5364839A
(en)
|
1990-06-18 |
1994-11-15 |
Genetics Institute, Inc. |
Osteoinductive pharmaceutical formulations
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
AU664976B2
(en)
|
1990-08-29 |
1995-12-14 |
Gene Pharming Europe Bv |
Homologous recombination in mammalian cells
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
DE69127627T2
(de)
|
1990-08-29 |
1998-02-19 |
Genpharm Int |
Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
WO1994025585A1
(en)
|
1993-04-26 |
1994-11-10 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5194594A
(en)
|
1990-09-07 |
1993-03-16 |
Techniclone, Inc. |
Modified antibodies
|
WO1992010210A1
(en)
|
1990-12-14 |
1992-06-25 |
E.I. Du Pont De Nemours And Company |
Inhibition of angiogenesis by il-1
|
US5206023A
(en)
|
1991-01-31 |
1993-04-27 |
Robert F. Shaw |
Method and compositions for the treatment and repair of defects or lesions in cartilage
|
WO1992020373A1
(en)
|
1991-05-14 |
1992-11-26 |
Repligen Corporation |
Heteroconjugate antibodies for treatment of hiv infection
|
WO1992022670A1
(en)
|
1991-06-12 |
1992-12-23 |
Genpharm International, Inc. |
Early detection of transgenic embryos
|
AU2235992A
(en)
|
1991-06-14 |
1993-01-12 |
Genpharm International, Inc. |
Transgenic immunodeficient non-human animals
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
CA2116107A1
(en)
|
1991-09-05 |
1993-03-18 |
George Y. Wu |
Targeted delivery of poly-or oligonucleotides to cells
|
US5273033A
(en)
*
|
1991-09-19 |
1993-12-28 |
Murray Electronics Associates Limited Partnership |
Electrical stimulation for treatment of osteoarthritis
|
US5716805A
(en)
*
|
1991-10-25 |
1998-02-10 |
Immunex Corporation |
Methods of preparing soluble, oligomeric proteins
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
EP0746609A4
(en)
|
1991-12-17 |
1997-12-17 |
Genpharm Int |
NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
|
US5777085A
(en)
|
1991-12-20 |
1998-07-07 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with GPIIB/IIIA
|
WO1993016043A1
(en)
|
1992-02-18 |
1993-08-19 |
Otsuka Kagaku Kabushiki Kaisha |
β-LACTAM COMPOUND AND CEPHEM COMPOUND, AND PRODUCTION THEREOF
|
US5233409A
(en)
|
1992-02-25 |
1993-08-03 |
Schwab Karl W |
Color analysis of organic constituents in sedimentary rocks for thermal maturity
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
WO1993023556A1
(en)
*
|
1992-05-08 |
1993-11-25 |
Genentech, Inc. |
Antibodies to leukemia inhibitory factor
|
NZ253943A
(en)
|
1992-06-18 |
1997-01-29 |
Genpharm Int |
Transfering polynucleotides into eukaryotic cells using co-lipofection complexes of a cationic lipid and the polynucleotide
|
GB9214857D0
(en)
|
1992-07-13 |
1992-08-26 |
Medical Res Council |
Human nucleic acid fragments and their use
|
ES2301158T3
(es)
|
1992-07-24 |
2008-06-16 |
Amgen Fremont Inc. |
Produccion de anticuerpos xenogenicos.
|
PL174721B1
(pl)
|
1992-11-13 |
1998-09-30 |
Idec Pharma Corp |
Przeciwciało monoklonalne anty-CD20
|
US5536637A
(en)
*
|
1993-04-07 |
1996-07-16 |
Genetics Institute, Inc. |
Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
|
EP0703979B1
(en)
|
1993-06-04 |
2000-09-13 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Method for treating kaposi's sarcoma with antisense oligonucleotides
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
US6274711B1
(en)
*
|
1993-06-14 |
2001-08-14 |
Inserm, Institut National De La Sante Et De La Recherche Medicale |
Purified mammalian CTLA-8 antigens and related reagents
|
US5830877A
(en)
|
1993-08-26 |
1998-11-03 |
The Regents Of The University Of California |
Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
|
US5625825A
(en)
|
1993-10-21 |
1997-04-29 |
Lsi Logic Corporation |
Random number generating apparatus for an interface unit of a carrier sense with multiple access and collision detect (CSMA/CD) ethernet data network
|
WO1995022618A1
(en)
|
1994-02-22 |
1995-08-24 |
Dana-Farber Cancer Institute |
Nucleic acid delivery system, method of synthesis and uses thereof
|
US5444047A
(en)
*
|
1994-06-16 |
1995-08-22 |
Dipasquale; Gene |
Treatment of arthritic and post-surgical orthopedic conditions with Insulin-like Growth Factor-I
|
WO2000073452A2
(en)
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US5643763A
(en)
|
1994-11-04 |
1997-07-01 |
Genpharm International, Inc. |
Method for making recombinant yeast artificial chromosomes by minimizing diploid doubling during mating
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
DK0817847T4
(da)
*
|
1995-03-23 |
2009-10-05 |
Immunex Corp |
IL-17-receptor
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
US5573762A
(en)
*
|
1995-04-24 |
1996-11-12 |
Genentech, Inc. |
Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
US6074849A
(en)
|
1995-07-19 |
2000-06-13 |
Genetics Institute, Inc. |
Polynucleotides encoding human CTLA-8 related proteins
|
ATE295414T1
(de)
|
1995-07-19 |
2005-05-15 |
Inst Genetics Llc |
Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
|
US6902735B1
(en)
|
1995-07-19 |
2005-06-07 |
Genetics Institute, Llc |
Antibodies to human IL-17F and other CTLA-8-related proteins
|
DK0843961T3
(da)
|
1995-08-29 |
2007-05-21 |
Kirin Brewery |
Kimærisk mus og fremgangsmåde til at producere samme
|
WO1997020062A1
(en)
|
1995-12-01 |
1997-06-05 |
University Of Massachusetts |
Il-12 p40 subunit fusion polypeptides and uses thereof
|
JP2001501447A
(ja)
|
1996-01-11 |
2001-02-06 |
コリクサ コーポレイション |
乳癌の処置および診断のための組成物および方法
|
US6025130A
(en)
|
1996-04-04 |
2000-02-15 |
Mercator Genetics, Inc. |
Hereditary hemochromatosis gene
|
WO2002008284A2
(en)
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
WO2002000690A2
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
JP2001506982A
(ja)
|
1996-11-27 |
2001-05-29 |
イミュネックス・コーポレーション |
一酸化窒素産生の制御法
|
ATE549918T1
(de)
|
1996-12-03 |
2012-04-15 |
Amgen Fremont Inc |
Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
|
US6054559A
(en)
*
|
1997-01-28 |
2000-04-25 |
Smithkline Beecham Corporation |
Interleukin-1 receptor antagonist beta (IL-1raβ)
|
US6579520B2
(en)
*
|
1998-05-15 |
2003-06-17 |
Genentech, Inc. |
IL-17 related mammalian cytokine polypeptides (IL-17E)
|
US20020177188A1
(en)
*
|
1998-05-15 |
2002-11-28 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
WO2001040465A2
(en)
|
1999-11-30 |
2001-06-07 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
WO2000070050A1
(en)
|
1999-05-14 |
2000-11-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US6569645B2
(en)
*
|
1999-05-14 |
2003-05-27 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
DE69824719T2
(de)
|
1997-04-25 |
2005-06-30 |
Zymogenetics, Inc., Seattle |
Cytokinähnlicher faktor-7 aus säugetieren
|
AU8571198A
(en)
|
1997-07-16 |
1999-02-10 |
Human Genome Sciences, Inc. |
Interleukin-20
|
US6060284A
(en)
*
|
1997-07-25 |
2000-05-09 |
Schering Corporation |
DNA encoding interleukin-B30
|
PE20000183A1
(es)
|
1997-07-25 |
2000-03-11 |
Schering Corp |
Citoquinas de mamiferos y reactivos relacionados
|
US6482923B1
(en)
|
1997-09-17 |
2002-11-19 |
Human Genome Sciences, Inc. |
Interleukin 17-like receptor protein
|
DE69841140D1
(de)
|
1997-09-17 |
2009-10-22 |
Human Genome Sciences Inc |
Interleukin-17 rezeptor-ähnliches protein
|
US6562578B1
(en)
*
|
1999-01-11 |
2003-05-13 |
Schering Corporation |
IL-17-like cytokine binding compounds and antibodies
|
AU2004799A
(en)
|
1997-12-19 |
1999-07-12 |
Millennium Biotherapeutics, Inc. |
Novel embryo-derived interleukin related factor molecules and uses therefor
|
WO1999031969A2
(en)
|
1997-12-19 |
1999-07-01 |
American Home Products Corporation |
Transgenic animal model for degenerative diseases of cartilage
|
WO1999035267A1
(en)
|
1998-01-09 |
1999-07-15 |
Immunex Corporation |
Human and murine il-17d, cytokine related to interleukin-17: dna and polypeptides
|
EP1490386B1
(en)
|
1998-03-10 |
2008-08-13 |
Genentech, Inc. |
Novel polypeptide and nucleic acids encoding the same
|
NZ528703A
(en)
|
1998-03-25 |
2005-05-27 |
Genentech Inc |
Novel PRO337 polypeptides and nucleic acids encoding a neurotrimin polypeptide
|
US6218371B1
(en)
|
1998-04-03 |
2001-04-17 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
ES2292242T5
(es)
*
|
1998-05-15 |
2011-05-04 |
Genentech, Inc. |
Utilizaciones terapéuticas de polipéptidos homólogos de il-17.
|
US20050147609A1
(en)
|
1998-05-15 |
2005-07-07 |
Genentech, Inc. |
Use of anti-IL-17 antibody for the treatment of cartilage damaged by osteoarthritis
|
US20010023070A1
(en)
*
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
EP1443055A3
(en)
|
1998-05-29 |
2005-06-08 |
Human Genome Sciences, Inc. |
Interleukins-21 and 22
|
EP1082433A4
(en)
*
|
1998-05-29 |
2003-01-02 |
Human Genome Sciences Inc |
Interleukins 21 and 22
|
DK1114156T3
(da)
|
1998-09-17 |
2008-03-03 |
Zymogenetics Inc |
Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
|
AU6277799A
(en)
|
1998-10-02 |
2000-04-26 |
Eli Lilly And Company |
Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and usesthereof
|
JP2000186046A
(ja)
|
1998-10-14 |
2000-07-04 |
Snow Brand Milk Prod Co Ltd |
慢性関節リウマチ治療剤及び診断方法
|
WO2000042187A1
(en)
|
1999-01-11 |
2000-07-20 |
Schering Corporation |
Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses
|
WO2000042188A2
(en)
|
1999-01-11 |
2000-07-20 |
Schering Corporation |
Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
|
AU2596700A
(en)
|
1999-03-08 |
2000-09-28 |
Genentech Inc. |
Promotion or inhibition of angiogenesis and cardiovascularization
|
US6914128B1
(en)
*
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
KR20130105766A
(ko)
|
1999-03-25 |
2013-09-25 |
애보트 게엠베하 운트 콤파니 카게 |
사람 il-12에 결합하는 사람 항체 및 이의 제조방법
|
US20030082734A1
(en)
*
|
1999-06-01 |
2003-05-01 |
Dowling Lynette M. |
Mammalian receptor proteins; related reagents and methods
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
CA2378519C
(en)
|
1999-07-07 |
2011-01-25 |
Zymogenetics, Inc. |
Human cytokine receptor
|
US20030199041A1
(en)
*
|
1999-07-07 |
2003-10-23 |
Presnell Scott R. |
Interleukin-17 receptor homologue
|
AU7680300A
(en)
|
1999-08-18 |
2001-03-13 |
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
Human dna sequences
|
EP1208202A2
(en)
|
1999-09-01 |
2002-05-29 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
JP2003508088A
(ja)
|
1999-09-03 |
2003-03-04 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
52個のヒト分泌タンパク質
|
AU7445900A
(en)
*
|
1999-09-27 |
2001-04-30 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor protein, nr12
|
US20040043397A1
(en)
*
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
EP1240325B1
(en)
|
1999-12-23 |
2009-09-30 |
Genentech, Inc. |
Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
|
US6380362B1
(en)
|
1999-12-23 |
2002-04-30 |
Genesis Research & Development Corporation Ltd. |
Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
|
EP1254221A2
(en)
|
2000-01-06 |
2002-11-06 |
Protegene Inc. |
HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
|
EP1285084A1
(en)
|
2000-01-25 |
2003-02-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
EP1252312A1
(en)
|
2000-01-31 |
2002-10-30 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
WO2001057202A2
(en)
|
2000-02-04 |
2001-08-09 |
The Board Of Trustees Of The University Of Arkansas |
Evi27 gene sequences and protein encoded thereby
|
AU6802801A
(en)
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
JP2003526370A
(ja)
|
2000-03-16 |
2003-09-09 |
アムジェン インコーポレーテッド |
Il−17レセプター様分子およびその使用
|
US7094566B2
(en)
*
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
AR030554A1
(es)
|
2000-03-16 |
2003-08-27 |
Amgen Inc |
Moleculas similares a receptores il-17 y usos de las mismas
|
WO2001072323A2
(en)
*
|
2000-03-24 |
2001-10-04 |
Genentech, Inc. |
Use of insulin for the treatment of cartilagenous disorders
|
ATE416782T1
(de)
|
2000-04-18 |
2008-12-15 |
Schering Corp |
Medizinische verwendung von il-174 agonisten und antagonisten
|
US7422743B2
(en)
*
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
CA2408571C
(en)
*
|
2000-05-10 |
2014-04-29 |
Schering Corporation |
Mammalian receptor proteins; related reagents and methods
|
WO2001090358A2
(en)
|
2000-05-24 |
2001-11-29 |
Schering Corporation |
Mammalian receptor proteins; related reagents and methods
|
US20030096969A1
(en)
*
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU6531101A
(en)
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
CA2412626C
(en)
|
2000-06-22 |
2013-10-22 |
Amgen Inc. |
Il-17 molecules and uses thereof
|
CA2416456A1
(en)
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU2001277980A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Zymogenetics Inc. |
Human cytokine receptor
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
JP2002139499A
(ja)
*
|
2000-08-23 |
2002-05-17 |
Sanyo Electric Co Ltd |
化学物質センサおよび化学物質の検出方法
|
JP2002076897A
(ja)
*
|
2000-08-29 |
2002-03-15 |
Toshiba Corp |
Daコンバータ
|
US20070160576A1
(en)
*
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
WO2003014309A2
(en)
*
|
2001-08-07 |
2003-02-20 |
Immunex Corporation |
Interleukin-1 receptors in the treatment of diseases
|
US7103929B2
(en)
*
|
2002-03-12 |
2006-09-12 |
Little Rapids Corporation |
Disposable bedding with absorbent region
|
WO2004042009A2
(en)
*
|
2002-10-30 |
2004-05-21 |
Genentech, Inc. |
Inhibition of il-17 production
|
EP2108658B1
(en)
*
|
2003-03-10 |
2016-06-08 |
Merck Sharp & Dohme Corp. |
Uses of IL-23 antagonists; related reagents
|
JP2007537132A
(ja)
|
2003-06-23 |
2007-12-20 |
ジェネティクス インスティテュート,エルエルシー |
インターロイキン−22に対する抗体およびその使用
|
EP2277908A3
(en)
*
|
2003-07-08 |
2011-12-14 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides, antibodies and therapeutic uses thereof
|
WO2005046698A1
(en)
*
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Fused heterocyclic compounds
|
AU2004289304A1
(en)
*
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Pyridine compounds
|
CA2544920C
(en)
|
2003-11-21 |
2012-09-11 |
Celltech R & D Limited |
Method for the treatment of multiple sclerosis by inhibiting il-17 activity
|
EP1901768B1
(en)
*
|
2004-02-17 |
2011-11-16 |
Schering Corporation |
Methods of modulating il-23 activity; related reagents
|
US20050287593A1
(en)
*
|
2004-05-03 |
2005-12-29 |
Schering Corporation |
Use of cytokine expression to predict skin inflammation; methods of treatment
|
CA2565566A1
(en)
|
2004-05-03 |
2005-11-17 |
Schering Corporation |
Use of il-17 expression to predict skin inflammation; methods of treatment
|
GB0417487D0
(en)
|
2004-08-05 |
2004-09-08 |
Novartis Ag |
Organic compound
|
AR051444A1
(es)
*
|
2004-09-24 |
2007-01-17 |
Centocor Inc |
Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
|
GB0425569D0
(en)
|
2004-11-19 |
2004-12-22 |
Celltech R&D Ltd |
Biological products
|
RU2007129263A
(ru)
*
|
2005-02-14 |
2009-03-20 |
Вайет (Us) |
Антитела к интерлейкину-17f и другие антагонисты опосредуемой il-17f передачи сигналов и их применение
|
AU2006255686A1
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
DE602006009834D1
(de)
|
2005-09-01 |
2009-11-26 |
Schering Corp |
Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
EP3808769A1
(en)
|
2005-12-13 |
2021-04-21 |
Eli Lilly And Company |
Anti-il-17 antibodies
|
WO2007117749A2
(en)
|
2006-01-31 |
2007-10-18 |
Novartis Ag |
Il-17 antagonistic antibodies fpr treating cancer
|
US7790163B2
(en)
*
|
2006-03-10 |
2010-09-07 |
Zymogenetics, Inc. |
Antibodies that bind both IL-17A and IL-17F and methods of using the same
|
AU2007226627B2
(en)
*
|
2006-03-10 |
2012-09-20 |
Zymogenetics, Inc. |
Antibodies that bind both IL-17A and IL-17F and methods of using the same
|
EP2044118A2
(en)
|
2006-06-13 |
2009-04-08 |
Zymogenetics, Inc. |
Il-17 and il-23 antagonists and methods of using the same
|
TW200815469A
(en)
|
2006-06-23 |
2008-04-01 |
Astrazeneca Ab |
Compounds
|
GB0612928D0
(en)
|
2006-06-29 |
2006-08-09 |
Ucb Sa |
Biological products
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
GB0620729D0
(en)
|
2006-10-18 |
2006-11-29 |
Ucb Sa |
Biological products
|
JP5116842B2
(ja)
*
|
2007-04-27 |
2013-01-09 |
ザイモジェネティクス, インコーポレイテッド |
IL−17AおよびIl−17Fの両方に結合する抗体ならびにそれを使用する方法
|
CA2683145C
(en)
|
2007-04-27 |
2018-06-12 |
Katherine E. Lewis |
Antagonists to il-17a, il-17f, and il-23p19 and methods of use
|
EP2182943B1
(en)
|
2007-07-23 |
2016-10-26 |
Janssen Biotech, Inc. |
Methods and compositions for treating fibrosis related disorders using il-17 antagonists
|
WO2009026412A1
(en)
|
2007-08-21 |
2009-02-26 |
Children's Medical Center Corporation |
Treatment of airway hyperreactivity
|
WO2009082624A2
(en)
*
|
2007-12-10 |
2009-07-02 |
Zymogenetics, Inc. |
Antagonists of il-17a, il-17f, and il-23 and methods of using the same
|
GB0807413D0
(en)
|
2008-04-23 |
2008-05-28 |
Ucb Pharma Sa |
Biological products
|
KR20110025649A
(ko)
*
|
2008-05-05 |
2011-03-10 |
노비뮨 에스 에이 |
항-il-17a/il-17f 교차-반응성 항체 및 그의 사용 방법
|
US8790642B2
(en)
|
2008-08-29 |
2014-07-29 |
Genentech, Inc. |
Cross-reactive and bispecific anti-IL-17A/F antibodies
|
NZ591484A
(en)
|
2008-09-29 |
2012-09-28 |
Roche Glycart Ag |
Antibodies against human il 17 and uses thereof
|
CN102781470B
(zh)
|
2009-03-05 |
2016-01-20 |
Abbvie公司 |
Il-17结合蛋白
|
SG175276A1
(en)
*
|
2009-05-05 |
2011-11-28 |
Novimmune Sa |
Anti-il-17f antibodies and methods of use thereof
|
EP2493506B1
(en)
|
2009-10-30 |
2019-04-10 |
Janssen Biotech, Inc. |
Il-17a antagonists
|